Prognostic factors of hepatocellular carcinoma in the west: a multivariate analysis in 206 patients.
about
The mutational landscape of hepatocellular carcinomaPortal vein thrombosis: When to treat and how?A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma.Clinical studies of laser ablation in treatment of primary liver carcinoma-associated portal vein tumor thrombus.Sixty-five gene-based risk score classifier predicts overall survival in hepatocellular carcinoma.Diagnostic Value of Serum Level of Soluble Tumor Necrosis Factor Receptor IIα in Egyptian Patients With Chronic Hepatitis C Virus Infection and Hepatocellular Carcinoma.Review of 336 patients with hepatocellular carcinoma at Songklanagarind HospitalConstruction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients.Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: a systematic review.Evaluation of transarterial chemoembolization combined with percutaneous ethanol ablation for large hepatocellular carcinomaHepatocellular carcinoma in Central Europe: prognostic features and survival.Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.Combined cis-platinum and alpha interferon therapy of advanced hepatocellular carcinoma.Gender difference in clinicopathologic features and survival of patients with hepatocellular carcinoma.Clinical features of hepatocellular carcinoma in the elderly: a study of 91 patients older than 70 years.Yttrium-90 radioembolization for advanced inoperable hepatocellular carcinoma.Differential Proteomic Analysis of Gender-dependent Hepatic Tumorigenesis in Hras12V Transgenic Mice.Liver resection in the treatment of hepatocellular carcinoma.Emergency endoscopic variceal ligation following variceal rupture in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis: a retrospective study.Active treatments are a rational approach for hepatocellular carcinoma in elderly patients.Factors influencing hepatocellular carcinoma prognosis after hepatectomy: a single-center experienceMultimodality treatment of pancreatic cancer with liver metastases using chemotherapy, radiation therapy, and/or Chinese herbal medicineFrequency of elevated biomarkers in patients with cryptogenic hepatocellular carcinomaPrognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies.Gender-based outcomes differences in unresectable hepatocellular carcinoma.Decoding human liver cancer signatures.What is the best staging system for hepatocellular carcinoma in the setting of liver transplantation?Surgical resection of localized hepatocellular carcinoma: patient selection and special consideration.Systems biology approaches to decoding the genome of liver cancer.Complete Metabolic Response with Recanalization of Portal Vein Tumor Thrombosis after Sunitinib in a Patient with Advanced Hepatocellular Carcinoma.Lymphatic vessel endothelial hyaluronan receptor-1 is a novel prognostic indicator for human hepatocellular carcinoma.Extrahepatic metastasis risk of hepatocellular carcinoma based on α-fetoprotein and tumor staging parameters at cross-sectional imaging.Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombusLocoregional therapies for hepatocellular carcinoma: which patients are most likely to gain a survival advantage?Elevated serum vitamin B(12) levels in association with tumor markers as the prognostic factors predictive for poor survival in patients with hepatocellular carcinoma.Interrelationships among genetic C677T polymorphism of 5,10-methylenetetrahydrofolate reductase, biochemical folate status, and lymphocytic p53 oxidative damage in association with tumor malignancy and survivals of patients with hepatocellular carciFactors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy.Outcome of patients with hepatocellular carcinoma referred to a tertiary centre with availability of multiple treatment options including cadaveric liver transplantation.Quantitative Platelet Abnormalities in Patients With Hepatitis B Virus-Related Liver Disease.Venous invasion by hepatic tumors: imaging appearance and implications for management.
P2860
Q26777478-93E8E36B-C2C8-44D6-92AD-B3305C835DE7Q30278059-F12EF6EB-2E0B-4AFB-A14A-B8B486BA25B3Q33368982-73EE6A85-64A1-4B8F-AA98-6855589B5F53Q33510853-4D6A9E75-5E70-4037-A692-5BABD6D9F039Q33766930-819A7525-BBB4-4327-B6C7-F8FD6A303CECQ34461237-6BADCA3C-595D-4330-975C-DF6DF7ED06E0Q34511976-FC094080-0855-43F2-B78E-A485444F985AQ34522010-4B00B4B3-425B-4D45-B9B9-08EF52680F62Q34984056-1F0BF27B-4A88-4ADA-A643-B25A741B9C94Q35171603-AE3C59AB-C0DD-489E-83E6-DE128D262E67Q35362361-8CAEC586-D7E9-48F0-A14C-F5CCE391A477Q35362684-1A3CC0F4-7F70-4E5A-8BE8-6020BF333C2EQ35938726-F72D3AD9-1C20-4335-A8BB-BB0106D3C659Q36067465-092F5CD5-0BF8-4C00-9F98-E3A104883BB1Q36079732-0BE1E4D4-61BC-46F5-B281-67834F4467F0Q36326015-76629DED-F6CA-48A7-B414-1F4CF7A9168BQ36373621-97E2D9EA-8FE5-4C63-95F2-B35B64BFE80BQ36448689-698ACF72-C523-4197-9AF4-4D6A5F29EFB8Q36612038-9890FAC2-8407-4D26-967D-BBC80E657567Q36975081-5F444A3D-16A0-484C-A35A-6549E1E84CA9Q37015289-CD7109F4-416A-4B7E-AFCA-469130EC2924Q37120362-1B140056-8478-43D5-9DA7-5AD210180BE1Q37178560-A2443C02-DE74-43CA-9961-BEC742FB7B66Q37263149-414CE9FF-DCE8-4BF9-A475-8D682714C994Q37278203-2C7F6A75-56FF-4BF6-85DF-5EC757C0692AQ37431536-D2511297-F0F7-4FD8-A70F-1C92DD894D05Q37886890-53E99D16-6F2C-4F19-87F3-0123017D96F5Q38769255-991DDABC-E39E-49E5-AD10-12EF6BBDDF6DQ40248307-EBE57559-4B73-4220-8557-33BE6B05F79BQ41493315-0CABA024-DCD1-4E6D-934F-5371FDD30653Q41921063-F61F4835-5462-448B-9389-92CE463BF21CQ42649817-94ADC4AD-A32A-4673-901C-0D0F9C157ADAQ42726305-C2221D07-AD83-4DEC-A2D3-516B6CC0EC2FQ42995568-E853FF9F-6DC3-4156-A339-81E1A68A572AQ43184866-45AB68DE-5ED4-4061-9159-C92CB3C9AD1CQ43591529-A57C6489-6692-439C-8171-1E5529B2DD7FQ43924482-49DA5B5C-74CE-41DF-810B-0799BE33E9B4Q46964114-4ED1003B-6614-47E2-831B-F0A131814AE5Q47142999-B8D540EF-2DEA-4BE0-BAA5-3F7913AF857EQ50002836-B9FAB9FD-D3B2-42AA-BB01-C5E9F3F0979A
P2860
Prognostic factors of hepatocellular carcinoma in the west: a multivariate analysis in 206 patients.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Prognostic factors of hepatoce ...... iate analysis in 206 patients.
@en
type
label
Prognostic factors of hepatoce ...... iate analysis in 206 patients.
@en
prefLabel
Prognostic factors of hepatoce ...... iate analysis in 206 patients.
@en
P2093
P356
P1433
P1476
Prognostic factors of hepatoce ...... iate analysis in 206 patients.
@en
P2093
P2860
P304
P356
10.1002/HEP.1840120422
P407
P433
P577
1990-10-01T00:00:00Z